M. Fray

发表

Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.

P. Fish, G. Whitlock, A. Stobie, 2006, Bioorganic & medicinal chemistry letters.

Synthesis of substituted 5-aminomethyl tetrahydro-isoquinolines and dihydro-isoindoles

J. Mathias, M. Fray, P. Allen, 2006 .

N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.

P. Fish, T. Ryckmans, S. Phillips, 2009, Bioorganic & medicinal chemistry letters.

A practical drug discovery project at the undergraduate level.

J. Liddle, M. Fray, D. Coe, 2013, Drug discovery today.

Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.

Alan Stobie, P. Fish, G. Whitlock, 2008, Bioorganic & medicinal chemistry letters.

Relative binding affinities of integrin antagonists by equilibrium dialysis and liquid chromatography-mass spectrometry.

N. Oldham, M. Fray, T. Mcinally, 2015, ACS medicinal chemistry letters.

Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.

M. Fray, T. Mcinally, Joelle Le, 2014, ACS medicinal chemistry letters.

1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.

M. Fray, M. Parry, K Cooper, 1992, Journal of medicinal chemistry.

Enantiodifferentiation of dihydropyridine PAF antagonists

M. Fray, M. Parry, J. Steele, 1995 .

1,4-Dihydropyridines as Antagonists of Platelet Activating Factor. Part 1. Synthesis and Structure-Activity Relationships of 2-(4- Heterocyclyl)phenyl Derivatives.

M. Fray, M. Parry, J. Steele, 1993 .

The genetics of stamenoid petal production in oilseed rape (Brassica napus) and equivalent variation in Arabidopsis thaliana

E. J. Evans, G. Coupland, J. Goodrich, 1997, Theoretical and Applied Genetics.

N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.

P. Fish, G. Whitlock, A. Stobie, 2007, Bioorganic & medicinal chemistry letters.

A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.

N. Occleston, M. Fray, J. P. Huggins, 2003, Journal of medicinal chemistry.

N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.

P. Fish, G. Whitlock, A. Stobie, 2008, Bioorganic & medicinal chemistry letters.

Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.

D. J. Bull, A. Stobie, M. Fray, 2001, Journal of medicinal chemistry.

Investigation of Epimer Formation in Amide-Coupling Reactions: An Experiment for Advanced Undergraduate Students

M. Fray, 2014 .

An optically pure 1,4-dihydropyridine from a resolution catalysed by rabbit liver esterase

M. Fray, D. Crout, K. Cooper, 1992 .

Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.

D. J. Bull, M. Fray, M. Parry, 1995, Journal of Medicinal Chemistry.

Physiological assessment of apetalous flowers and erectophile pods in oilseed rape (Brassica napus)

E. J. Evans, D. Lydiate, M. Fray, 1996, The Journal of Agricultural Science.

Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.

M. Fray, R. Dickinson, M. Burslem, 2001, Bioorganic & medicinal chemistry letters.

Passing on the medicinal chemistry baton: training undergraduates to be industry-ready through research projects between the University of Nottingham and GlaxoSmithKline.

Simon J F Macdonald, M Jonathan Fray, Thomas McInally, 2016, Drug discovery today.

Novel antagonists of platelet-activating factor. 1. Synthesis and structure-activity relationships of benzodiazepine and benzazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.

M. Fray, M. Parry, J. Steele, 1995, Journal of medicinal chemistry.

Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).

M. Fray, R. Dickinson, 2001, Bioorganic & medicinal chemistry letters.

Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.

P. Fish, S. Phillips, G. Whitlock, 2010, Bioorganic & medicinal chemistry letters.